Annals of the Rheumatic Diseases
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update
✓ Free legal copy found
Published version, hosted by ard.bmj.com
This is the final version, as it appears in the journal.
Read the free PDF →Other free copies
- doi.orgPublished version · Web page
- Maastricht University (cris.maastrichtuniversity.nl)Published version · Web page
- University of Manchester (research.manchester.ac.uk)Published version · Web page
- University of Manchester (research.manchester.ac.uk)Published version · Web page
- Erasmus University Rotterdam (hdl.handle.net)Accepted manuscript · Web page
- University of Florence (flore.unifi.it)Preprint · PDF
- pure.amsterdamumc.nlPreprint · PDF
- repositorio.ulisboa.ptPreprint · PDF
- Leiden University (ard.bmj.com)Preprint · PDF
- University of Geneva (access.archive-ouverte.unige.ch)Preprint · PDF
- Royal Netherlands Academy of Arts and Sciences (pure.amc.nl)Preprint · Web page
- Royal Netherlands Academy of Arts and Sciences (hdl.handle.net)Preprint · Web page
- eprints.gla.ac.ukPreprint · Web page
- University of Birmingham (research.birmingham.ac.uk)Preprint · Web page
- University of Birmingham (research.birmingham.ac.uk)Preprint · Web page
- Erasmus University Rotterdam (repub.eur.nl)Preprint · Web page
- hdl.handle.netPreprint · Web page
- hdl.handle.netPreprint · Web page
DOI: 10.1136/annrheumdis-2016-210715 · Publisher: Elsevier BV